Stockholm-Uppsala Region may become new home of EMA

As a result of the UK decision to leave the EU, several EU agencies are planning to leave the UK, including the European Medicines Agency (EMA). On Thursday, the Government of Sweden decided to actively work for EMA to be located in Sweden and the Stockholm-Uppsala region in particular. This decision is welcomed by Stockholm Business Region.

The Stockholm-Uppsala region is one of Europe’s strongest life science clusters, comprising a number of significant public and private stakeholders. The region is home to a large part of the most prominent biomedical research and the Swedish life science industry. Together with several stakeholders, the region has worked hard to attract EMA following Brexit, efforts that are now shifting into high gear to compete with other life science clusters in Europe.

Read the press release in our Newsroom »